Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
COR
MRNA
Add up to 3 more stocks
COR
Cencora, Inc.
+0.31%
$317.10+0.97At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$61.70B
52W Range
$244.82 - $377.54
MRNA
Moderna, Inc.
+176.97%
$174.38+111.42At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$69.19B
52W Range
$22.28 - $176.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 23.56 | N/A |
| Forward P/E | 17.79 | N/A |
| P/B Ratio | 20.16 | 10.21 |
| P/S Ratio | 0.18 | 30.99 |
| P/FCF Ratio | 15.15 | N/A |
| EV/EBITDA | 13.07 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 3.7% | 55.4% |
| Operating Margin | 1.3% | -158.1% |
| Net Margin | 0.8% | -141.4% |
| ROE | 86.0% | -46.6% |
| ROA | 3.1% | -28.8% |
| ROIC | 12.8% | -39.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.93 | 2.29 |
| Quick Ratio | 0.58 | 2.18 |
| Debt/Equity | 3.84 | 0.19 |
| Interest Coverage | 8.69 | -307.40 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.7% | N/A |
| Payout Ratio | 29.3% | N/A |
| Yrs of Dividend Growth | 20 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.